Business Standard

Sun Pharma gains on acquisition of URL generic biz

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco.

Related News

Sun Pharmaceutical Industries is trading higher by 2% at Rs 732 after the company said it has buys generic business of pharma through its subsidiary for an undisclosed amount.

“Caraco Pharmaceutical Laboratories, wholly-owned subsidiary of the company, has entered into a definitive agreement with Pharmaceuticals U.S.A., Inc, a wholly-owned subsidiary of Takeda Pharmaceutical Company, to buy the URL Pharma, Inc. generic business,” said in a statement.

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco. The deal is subject to satisfaction of customary closing conditions, including applicable regulatory approvals, it added.

The stock opened at Rs 727 and hit a high of Rs 733 on the NSE. A combined 138,547 shares have changed hands on the counter in morning deals.

Read more on:   
|
|

Sun Pharma gains on acquisition of URL generic biz

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco.

Sun Pharmaceutical Industries is trading higher by 2% at Rs 732 after the company said it has buys generic business of URL pharma through its subsidiary for an undisclosed amount.

Sun Pharmaceutical Industries is trading higher by 2% at Rs 732 after the company said it has buys generic business of URL pharma through its subsidiary for an undisclosed amount.

“Caraco Pharmaceutical Laboratories, wholly-owned subsidiary of the company, has entered into a definitive agreement with Takeda Pharmaceuticals U.S.A., Inc, a wholly-owned subsidiary of Takeda Pharmaceutical Company, to buy the URL Pharma, Inc. generic business,” Sun Pharma said in a statement.

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco. The deal is subject to satisfaction of customary closing conditions, including applicable regulatory approvals, it added.

The stock opened at Rs 727 and hit a high of Rs 733 on the NSE. A combined 138,547 shares have changed hands on the counter in morning deals.

image

Read More

Two entities fail to make prima facie case to revoke ban: Sebi

The Securities and Exchange Board of India (Sebi) today said the restraining order on two entities, related to plunge in some mid-cap stocks in July, ...

Recommended for you

Quick Links

Market News

Why are cane growers angry with the govt and not factories?

What has got farmers seething in anger is the government's indifference to rapidly growing arrears in cane payment by factories

Today's picks- 30 March 2015

Nifty, Bank Nifty, Idea Cellular, Cairn India & Larsen & Toubro

MCX sells MSXI warrants worth Rs 2.2 crore to IL&FS

This is the second such sale of MSXI warrants by MCX to IL&FS this month

GVK to file up to Rs 1,500-cr IPO for airport unit soon

GVK has mandated Citigroup, Bank of America-Merrill Lynch, Axis Capital and JM Financial Services to manage the IPO

Wheat output may fall by 2% this year due to unseasonal rains

Wheat has suffered damage at over 62 lakh hectare due to unseasonal rains and hailstorms, which occurred in three phases between Feb 28 and Mar ...

 

Back to Top